InvestorsHub Logo
Followers 355
Posts 9910
Boards Moderated 2
Alias Born 06/23/2007

Re: None

Wednesday, 10/07/2015 10:04:42 AM

Wednesday, October 07, 2015 10:04:42 AM

Post# of 55034
$XXII a Pharma Play?

Given the results published in the NEJM, I think there's potential down the road for insurance companies to pay for XXII ciggs. The FDA are in the driver's seat regarding regulation of the drug. It's possible (but would take clinical trials with a big pharma partner I would think) for the ciggs to be prescribed like Chantix is, as a smoking cessation drug, with insurance companies reimbursing.

So big pharma may find XXII attractive as well, not just big tobacco

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News